More than 800 million adults have diabetes worldwide – almost twice as many as previous estimates have suggested.

Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...

An international, phase 3 clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare disease that can cause debilitating symptoms.

Bayer will present three new prespecified subgroup analyses from the pivotal Phase III FINEARTS-HF cardiovascular outcomes trial investigating KERENDI ...

KHOU 11 News anchor Rekha Muddaraj spoke to an endocrinologist with UT Physicians about the chronic disease and what to look ...

Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...

An estimated 5.6 million people in the UK are living with diabetes and rates are rising. Recent figures showed that 549,000 more people have been identified over the past year as being at risk of ...

People with chronic kidney disease and type 2 diabetes may face heart disease up to 28 years earlier than others.

In the fight against diabetes, early detection is crucial. Too often, the diagnosis happens only after the disease has taken ...

Several districts across Nagaland observed World Diabetes Day on Thursday on the theme “Breaking barriers, bridging gaps.” ...

KEY BUSINESS HIGHLIGHTSPhase 2a clinical trial for Cholesterol Efflux Mediator™ VAR 200 in patients with diabetic kidney disease expected to ...

On World Diabetes Day, we talk to experts about the causes, symptoms and treatment of type 1 and 2 diabetes ... That can ...